Dermavant Sciences’ $200 Million Financing

Federica Tiefenthaler Europe, Europe Legal Chronicle
Tagged:

VISCHER acted as Swiss counsel to Dermavant in the transaction.Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, entered into…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Federica Tiefenthaler

Author: Federica Tiefenthaler

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here